当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析

圣湘生物

(688289)

  

流通市值:82.85亿  总市值:82.85亿
流通股本:5.79亿   总股本:5.79亿

圣湘生物(688289)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.42亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益722951.10万元,未分配利润484048.25万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产960677.05万元,负债237725.95万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入437,346,014.851,641,533,008.191,244,138,989.62868,620,485.26
营业总成本373,874,252.961,396,281,013.981,066,909,188.78702,919,097.81
其他经营收益
营业利润52,067,500.64203,271,353.27197,307,297.13191,549,753.11
利润总额51,115,050.72175,083,963.55179,774,191.79170,608,533.67
净利润41,791,587.9153,924,782.58161,975,915.54142,740,148.15
每股收益
其他综合收益-1,865,099.45-8,298,918.92-1,751,561.64607,182.97
综合收益总额39,926,488.45145,625,863.66160,224,353.9143,347,331.12
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计5,160,630,982.145,274,236,741.685,304,688,974.995,382,425,770.87
非流动资产:
非流动资产合计4,446,139,565.834,252,443,134.724,159,497,737.014,137,507,471.86
资产总计9,606,770,547.979,526,679,876.49,464,186,7129,519,933,242.73
流动负债:
流动负债合计1,210,638,624.741,206,016,603.911,087,825,915.221,155,569,953.81
非流动负债:
非流动负债合计1,166,620,915.861,130,565,486.931,156,270,967.521,010,715,687.89
负债合计2,377,259,540.62,336,582,090.842,244,096,882.742,166,285,641.7
所有者权益(或股东权益):
归属于母公司股东权益合计7,163,991,732.827,116,117,505.447,130,763,929.237,254,955,843.64
股东权益合计7,229,511,007.377,190,097,785.567,220,089,829.267,353,647,601.03
负债和股东权益合计9,606,770,547.979,526,679,876.49,464,186,7129,519,933,242.73
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计432,778,063.341,902,175,993.211,276,260,976.7785,729,209.73
经营活动现金流出小计433,742,451.491,718,215,149.511,360,741,028.37928,576,050.75
经营活动产生的现金流量净额-964,388.15183,960,843.7-84,480,051.67-142,846,841.02
投资活动产生的现金流量:
投资活动现金流入小计25,282,615.16849,946,342.59996,450,999.11715,866,825.58
投资活动现金流出小计272,150,764.92,136,140,051.041,992,442,263.211,615,358,695.17
投资活动产生的现金流量净额-246,868,149.74-1,286,193,708.45-995,991,264.1-899,491,869.59
筹资活动产生的现金流量:
筹资活动现金流入小计77,128,870.151,118,393,717.311,109,084,474.13949,084,474.13
筹资活动现金流出小计36,037,921.71744,016,301.94759,047,028.32580,155,764.45
筹资活动产生的现金流量净额41,090,948.44374,377,415.37350,037,445.81368,928,709.68
汇率变动对现金及现金等价物的影响-3,987,574.39-2,230,122.3-389,317.971,279,806.12
现金及现金等价物净增加额-210,729,163.84-730,085,571.68-730,823,187.93-672,130,194.81
期末现金及现金等价物余额3,535,813,281.43,746,542,445.243,745,804,828.993,804,497,822.11
补充资料:
现金及现金等价物的净增加额--730,085,571.68--672,130,194.81
最新报告期:2026-05-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投喻胜锋,李虹达,王在存,贺菊颖0.400.440.482026-05-28
兴业证券东楠,孙媛媛,黄翰漾,龚涵清0.400.520.622026-05-15
中泰证券祝嘉琦,谢木青0.420.550.632026-05-14
湘财证券蒋栋0.450.480.512026-05-12
华源证券刘闯,林海霖0.480.600.712026-05-09
TOP↑